ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS

European Respiratory Journal

Volumn 29, Issue 3, 2007, Pages 482-488

  Adamzik, Michael ^a   Frey, U ^a   Sixt, S ^a   Knemeyer, L ^a   Beiderlinden, M ^a   Peters, J ^a   Siffert, W ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acute respiratory distress syndrome; Angiotensin converting enzyme insertion deletion polymorphism; Intrapulmonary renin angiotensin system

Indexed keywords

ALANINE; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RISK FACTOR; SURVIVAL TIME;

ADULT; ALLELES; ANGIOTENSINS; CHROMOSOME DELETION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; INTRONS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SURVIVAL RATE;

EID: 33847715987     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00046106     Document Type: Article

References (44)

1. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003; 167: 1027-1035.
2. Villar J, Flores C, Mendez-Alvarez S. Genetic susceptibility to acute lung injury. Crit Care Med 2003; 31: S272-S275.
3. Yamamoto T, Wang L, Shimakura K, Sanaka M, Koike Y, Mineshita S. Angiotensin II-induced pulmonary edema in a rabbit model. Jpn J Pharmacol 1997; 73: 33-40.
4. Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ, Lipworth BJ. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc Res 1997; 33: 201-208.
5. Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000; 55: 143-146.
6. Fourrier F, Chopin C, Wallaert B, Mazurier C, Mangalaboyi J, Durocher A. Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS. Chest 1985; 87: 191-195.
7. Kageyama R, Ohkubo H, Nakanishi S. Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence. Biochemistry 1984; 23: 3603-3609.
8. Nakanishi S, Ohkubo H, Nawa H, Kitamura N, Kageyama R, Ujihara M. Angiotensinogen and kininogen: cloning and sequence analysis of the cDNAs. Clin Exp Hypertens A 1983; 5: 997-1003.
9. Liu YH, Yang XP, Mehta D, Bulagannawar M, Scicli GM, Carretero OA. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats. Am J Physiol Heart Circ Physiol 2000; 278: H507-H514.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
11. Idell. S, Kueppers F, Lippmann M, Rosen H, Niederman M, Fein A. Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest 1987; 91: 52-56.
12. Wenz M, Steinau R, Gerlach H, Lange M, Kaczmarczyk G. Inhaled nitric oxide does not change transpulmonary angiotensin II formation in patients with acute respiratory distress syndrome. Chest 1997; 112: 478-483.
13. Wiberg-Jorgensen F, Klausen NO, Hald A, Qvist J, Giese J, Damkjaer Neilsen M. Pulmonary angiotensin II production in respiratory failure. Clin Physiol 1983; 3: 59-67.
14. Baudin B. New aspects on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med 2002; 40: 256-265.
15. Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002; 166: 646-650.
16. Gould AB, Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res 1971; 5: 86-89.
17. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786-1797.
18. Jeunemaitre X. Polymorphismes génétiques du systeme rénine-angiotensine: Actualités sur la Système Rénine-Angiotensine-Aldostérone. [Genetic polymorphisms; in the renin-angiotensin system]. Théapie 1998; 53: 271-277.
19. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
20. Bone RC. The sepsis syndrome. Definition and general approach to management. Clin Chest Med 1996; 17: 175-181.
21. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963.
22. Peres Bota D, Melot C, Lopes Ferreira F, Nguyen Ba V, Vincent JL. The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction. Intensive Care Med 2002; 28: 1619-1624.
23. Siffert W, Forster P, Jockel KH, et al. Worldwide ethnic distribution of the G protein β3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999; 10: 1921-1930.
24. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism. and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711.
25. Ahmadian A, Gharizadeh B, Gustafsson AC, et al. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem 2000; 280: 103-110.
26. Furuya K, Yamaguchi E, Kawakami Y. [Angiotensin-converting enzyme (ACE) polymorphism and serum ACE activities in sarcoidosis]. Nippon Rinsho 1994; 52: 1561-1566.
27. Benessiano J, Crestani B, Mestari F, et al. High frequency of a deletion polymorphism. of the angiotensin-converting enzyme gene in asthma. J Allergy Clin Immunol 1997; 99: 53-57.
28. Maier LA, Raynolds MV, Young DA, Barker EA, Newman LS. Angiotensin-1 converting enzyme polymorphisms, in chronic beryllium disease. Am J Respir Crit Care Med 1999; 159: 1342-1350.
29. Cargill RI, Kiely DG, Clark RA, Lipworth BJ. Hypoxaemia and release of endothelin-1. Thorax 1995; 50: 1308-1310.
30. Xu ZH, Shimakura K, Yamamoto T, Wang LM, Mineshita S. Pulmonary edema induced by angiotensin I in rats. Jpn J Pharmacol 1998; 76: 51-56.
31. Wang R, Zagariya A, Ang E, Ibarra-Sunga O, Uhal BD. Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction. Am J Physiol 1999; 277: L1245-L1250.
32. Chesnutt AN, Matthay MA, Tibayan FA, Clark JG. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 1997; 156: 840-845.
33. Ward WF, Molteni A, Ts'ao CH, Hinz JM. Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 1990; 19: 1405-4409.
34. Guazzi M, Melzi G, Marenzi GC, Agostoni P. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction. Clin Pharmacol Ther 1999; 65: 319-327.
35. Suzuki M, Teramoto S, Katayama H, Ohga E, Matsuse T, Ouchi Y. Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages. J Asthma 1999; 36: 665-670.
36. Fishel RS, Eisenberg S, Shai SY, Redden RA, Bernstein KE, Berk BC. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 1995; 25: 343-349.
37. Zhao X, White R, Huang BS, Van Huysse J, Leenen FH. High salt intake and the brain renin-angiotensin system in Dahl salt-sensitive rats. J Hypertens 2001; 19: 89-98.
38. Keavney B, McKenzie CA, Connell JM, et al. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 1998; 7: 1745-1751.
39. Brand E, Chatelain N, Keavney B, et al. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 1998; 31: 725-729.
40. Chan KC, Tang NL, Hui DS, et al. Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study. BMC Infect Dis 2005; 5: 26.
41. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995; 152: 1818-1824.
42. Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med 1998; 157: 1159-1164.
43. Sloane PJ, Gee MH, Gottlieb JE, et al. A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis 1992; 146: 419-426.
44. Han Y, Runge MS, Brasier AR. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-KB transcription factors. Circ Res 1999; 84: 695-703.